Oral Zn-Telomir Monotherapy in Patients With Advanced or Metastatic Triple-Negative Breast Cancer (TNBC)

计划入组 76 人 · 首次发布于 2026 年 5 月 12 日

Efficacy of Zn Biofortified Wheat in Improving Zn Status in Indian School Children With Low Zn Status

计划入组 284 人 · 首次发布于 2014 年 9 月 16 日

Absorption of Zinc (Zn) From Zn-biofortified and Zn-fortified Maize in Young Zambian Children Between 24-36 Months

计划入组 60 人 · 首次发布于 2014 年 8 月 5 日

TELOMIR-1

ZN-2007

ZN-002

TELOMIR PHARMACEUTICALS, INC.

United States

Telomir-Zn Suppresses Tumor Growth in TNBC and Prostate Cancer Models via Iron-Dependent KDM Inhibition, Preclinical Study Shows

Telomir Pharmaceuticals Secures Global Rights to Telomir-1 Through TELI Acquisition, Advances Toward Triple-Negative Breast Cancer Trial

Telomir Pharmaceuticals' Telomir-1 Shows Copper-Binding Potential for Wilson's Disease Treatment